Business Wire - Biovail Reports Positive CardizemLA Launch Results
Monday, November 10th, 2008 Business Editors/Health/Medical Writers
TORONTO–(BUSINESS WIRE)–April 29, 2003
— CardizemLA Prescriptions Exceed 20,000
— Retail Pharmacy Stocking Reaches 80%
— Managed Care Negotiations Cover 90% of U.S. Lives
Biovail Corporation (NYSE:BVF)(TSX:BVF) reported today on the progress of Cardizem(R)LA (diltiazem HCl), the recently launched once-daily controlled release medication for the treatment of hyperte…
